ArticleJournal of thoracic disease2018

NIBIT-MESO-1: limitations and clinical perspectives in MPM treatment testing an immune checkpoint blockade combination in a single-arm study.

Paolo Bironzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.